Britta Mazur

Britta Mazur has extensive experience in the field of medical science liaison and account management. Britta currently holds the position of Medical Scientific Liaison Manager Oncology at Stemline Therapeutics, starting in August 2022. Prior to this, they worked at Daiichi Sankyo Deutschland GmbH as a Senior Medical Science Liaison Manager Oncology from April 2021 to August 2022, and as a Medical Science Liaison Manager Oncology from April 2019 to April 2021. Before their time at Daiichi Sankyo Deutschland GmbH, they worked at Daiichi Sankyo Oncology Europe GmbH as a Medical Science Liaison Manager Oncology from July 2017 to April 2019. Britta's earlier experience includes roles at Daiichi Sankyo Deutschland GmbH as a Medical Scientific Liaison Manager Oncology from February 2017 to July 2017, as a Medical Scientific Liaison Manager West (Cardiology) from October 2012 to February 2017, as a Key-Account-Manager (Cardiology) from October 2009 to October 2012, and as a Wissenschaftlicher Außendienst from September 1998 to September 2009. Britta began their career at Co-Pharma Außendienst GmbH as a Wissenschaftlicher Außendienst from August 1997 to September 1998. Britta Mazur has accumulated a wealth of experience in the pharmaceutical industry, specializing in oncology and cardiology.

From 1990 to 1997, Britta Mazur attended The University of Bonn, where they earned a Diplom degree in Biologie, allgemein.